Viridian Therapeutics, Inc. (VRDN): This Small-Cap Stock Is Ready To Explode

Yahoo FinanceNov 19 08:47 ET

Viridian Therapeutics (VRDN) Pioneering Breakthroughs in Thyroid Eye Disease

TipRanksNov 18 05:29 ET

Viridian Therapeutics Analyst Ratings

BenzingaNov 14 05:06 ET · Ratings

Viridian Therapeutics: Promising FcRn Inhibitor Developments and Strong Buy Recommendation

TipRanksNov 14 02:45 ET

H.C. Wainwright Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Raises Target Price to $34

Moomoo NewsNov 13 12:31 ET · Ratings

In-Depth Examination Of 11 Analyst Recommendations For Viridian Therapeutics

BenzingaNov 13 11:00 ET